WARD 24/7 is a health technology startup based in Copenhagen, founded in 2019. The company specializes in AI-driven patient monitoring, focusing on real-time detection of patient deterioration through clinically validated algorithms that analyze vital signs from wireless sensors. Their main product, the WARD Clinical Support System (WARD-CSS), is an FDA-cleared and CE-certified software solution. It aims to enhance hospital patient monitoring by addressing the limitations of manual vital sign checks, which can overlook critical trends. WARD-CSS integrates with wireless sensors to provide real-time interpretation of vital sign patterns, generating alerts that help prevent complications and improve patient outcomes. The company operates on a B2B SaaS model, targeting hospitals and healthcare providers to optimize workflows and reduce healthcare demands. WARD 24/7 has raised a total of $6.44 million in funding and is actively involved in various innovation projects in Denmark. The team includes experienced professionals in the fields of healthcare and technology.